Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Exousia Bio (LMMY) Shares Issued (2023)

Lamy (LMMY) has disclosed Shares Issued for 1 consecutive years, with $22270.0 as the latest value for Q2 2023.

  • Quarterly Shares Issued changed N/A to $22270.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $22270.0 through Feb 2024, changed N/A year-over-year, with the annual reading at $25270.0 for FY2023, N/A changed from the prior year.
  • Shares Issued hit $22270.0 in Q2 2023 for Lamy, up from $3000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $22270.0 in Q2 2023 to a low of $3000.0 in Q1 2023.